Enhancing protective immunity to malaria with a highly immunogenic virus-like particle vaccine

Enhancing protective immunity to malaria with a highly immunogenic virus-like particle vaccine

The leading malaria vaccine in development is the circumsporozoite (CS) protein-based vaccine, RTS,S, which targets the pre-erythrocytic stage of Plasmodium falciparum infection. It induces modest levels of protective efficacy largely mediated by CS specific antibodies. We aimed to enhance vaccine e...

Полное описание

Библиографические подробности
Главные авторы:	Gilbert, S, Collins, K, Snaith, R, Cottingham, M, Hill, A
Формат:	Journal article
Опубликовано:	Nature Publishing Group 2017

Схожие документы

Inclusion of cGAMP within virus-like particle vaccines enhances their immunogenicity
по: Chauveau, L, и др.
Опубликовано: (2021)

Virus-like particles as vaccine adjuvants.
по: Gilbert, S
Опубликовано: (2001)

Virus-like particle vaccines
по: Mukhopadhyay, E, и др.
Опубликовано: (2022)

Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara.
по: Schneider, J, и др.
Опубликовано: (1998)

Gene gun intradermal DNA immunization followed by boosting with modified vaccinia virus Ankara: enhanced CD8+ T cell immunogenicity and protective efficacy in the influenza and malaria models.
по: Dégano, P, и др.
Опубликовано: (1999)

Safety and immunogenicity of DNA/modified vaccinia virus ankara malaria vaccination in African adults.
по: Moorthy, V, и др.
Опубликовано: (2003)

Protein particle vaccines against malaria.
по: Gilbert, S, и др.
Опубликовано: (1997)

The requirement for potent adjuvants to enhance the immunogenicity and protective efficacy of protein vaccines can be overcome by prior immunization with a recombinant adenovirus.
по: de Cassan, S, и др.
Опубликовано: (2011)

A vaccine for hypertension based on virus-like particles: preclinical efficacy and phase I safety and immunogenicity.
по: Ambühl, P, и др.
Опубликовано: (2007)

Virus-like particle (VLP) plus microcrystalline tyrosine (MCT) adjuvants enhance vaccine efficacy improving T and B cell immunogenicity and protection against Plasmodium berghei/vivax
по: Cabral-Miranda, G, и др.
Опубликовано: (2017)

Ty virus-like particles, DNA vaccines and Modified Vaccinia Virus Ankara; comparisons and combinations.
по: Gilbert, S, и др.
Опубликовано: (1999)

Enhanced immunogenicity of CD4(+) t-cell responses and protective efficacy of a DNA-modified vaccinia virus Ankara prime-boost vaccination regimen for murine tuberculosis.
по: Mcshane, H, и др.
Опубликовано: (2001)

Complete protective immunity against blood-stage malaria induced by heterologous prime-boost vaccination
по: Draper, S, и др.
Опубликовано: (2005)

Anti-CD25 antibody enhancement of vaccine-induced immunogenicity: increased durable cellular immunity with reduced immunodominance.
по: Moore, A, и др.
Опубликовано: (2005)

Der p 1 peptide on virus-like particles is safe and highly immunogenic in healthy adults.
по: Kündig, T, и др.
Опубликовано: (2006)

Allergens displayed on virus-like particles are highly immunogenic but fail to activate human mast cells.
по: Engeroff, P, и др.
Опубликовано: (2017)

Evaluation of the immunogenicity of a promising vaccine regimen to identify immune correlates of protection
по: Pinpathomrat, N
Опубликовано: (2018)

Immunogenicity of vaccines for malaria-exposed populations
по: Bowyer, GSA
Опубликовано: (2018)

The coming of age of virus-like particle vaccines.
по: Jennings, G, и др.
Опубликовано: (2008)

Protection against osteoporosis by active immunization with TRANCE/RANKL displayed on virus-like particles.
по: Spohn, G, и др.
Опубликовано: (2005)

Enhancing blood-stage malaria subunit vaccine immunogenicity in rhesus macaques by combining adenovirus, poxvirus, and protein-in-adjuvant vaccines.
по: Draper, S, и др.
Опубликовано: (2010)

Preclinical antihypertensive efficacy and immunogenicity in humans of a vaccine against angiotensin II based on virus-like particles (VLPs)
по: Tissot, A, и др.
Опубликовано: (2005)

Immunogenic recombinant Mayaro virus-like particles present natively assembled glycoprotein
по: Kim, YC, и др.
Опубликовано: (2024)

Engineering a modular virus-like particle platform for enhanced vaccine assembly
по: Wu, H-J
Опубликовано: (2022)

Enhanced CD8 T cell immunogenicity and protective efficacy in a mouse malaria model using a recombinant adenoviral vaccine in heterologous prime-boost immunisation regimes.
по: Gilbert, S, и др.
Опубликовано: (2002)

Active immunization with IL-1 displayed on virus-like particles protects from autoimmune arthritis.
по: Spohn, G, и др.
Опубликовано: (2008)

Safety and immunogenicity of heterologous prime-boost immunization with viral-vectored malaria vaccines adjuvanted with Matrix-M
по: Venkatraman, N, и др.
Опубликовано: (2017)

Improved systems for generating and evaluating adenovirus vaccine vectors reveal differences in immunogenicity between vectors of different adenoviral species
по: Dicks, M, и др.
Опубликовано: (2011)

Virus-like particles of macrobrachium rosenbergii nodavirus capsid as a carrier for immunogenic components
по: Tan, Wen Siang, и др.
Опубликовано: (2014)

Anti-CD25 antibody enhancement of vaccine-induced immunogenicity to bacterial, viral and parasitic antigens: increased durable cellular immunity with reduced immunodominance
по: Moore, A, и др.
Опубликовано: (2005)

Comparison of the immunogenicity and protection against bovine tuberculosis following immunization by BCG-riming and boosting with adenovirus or protein based vaccines
по: Dean, G, и др.
Опубликовано: (2014)

Comparison of the immunogenicity and protection against bovine tuberculosis following immunization by BCG-priming and boosting with adenovirus or protein based vaccines.
по: Dean, G, и др.
Опубликовано: (2014)

Virus like particles as a platform for cancer vaccine development
по: Hui, Kian Ong, и др.
Опубликовано: (2017)

Versatile virus-like particle carrier for epitope based vaccines
по: Tissot, A, и др.
Опубликовано: (2010)

Virus-like particles as a modular system for novel vaccines.
по: Lechner, F, и др.
Опубликовано: (2002)

4-1BBL enhances CD8+ T cell responses induced by vectored vaccines in mice but fails to improve immunogenicity in rhesus macaques.
по: Spencer, A, и др.
Опубликовано: (2014)

Efficient induction of mucosal and systemic immune responses by virus-like particles administered intranasally: implications for vaccine design.
по: Bessa, J, и др.
Опубликовано: (2008)

Potent immunogenicity and protective efficacy of a multi-pathogen vaccination targeting Ebola, Sudan, Marburg and Lassa viruse
по: Flaxman, A, и др.
Опубликовано: (2024)

Phase 1 evaluation of 3 highly immunogenic prime-boost regimens, including a 12-month reboosting vaccination, for malaria vaccination in Gambian men.
по: Moorthy, V, и др.
Опубликовано: (2004)

Prime-boost immunization with adenoviral and modified vaccinia virus Ankara vectors enhances the durability and polyfunctionality of protective malaria CD8+ T-cell responses.
по: Reyes-Sandoval, A, и др.
Опубликовано: (2010)